Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular Disorders
Sponsored by Mansoura University
About this trial
Last updated 3 months ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 4 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Age: 19 - 45 years.
* Diagnosis of myofascial pain according to the Research Diagnostic Criteria for TMD Axis I (RDC/TMD).
* Pain upon digital palpation of the masseter and/or the temporalis muscles.
* Patients with disc displacement with or without reduction in any of the TMJs.
* Co-operative patients.
Exclusion Criteria
* Diagnosed systemic muscular or joint diseases (e.g. fibromyalgia, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis).
* Whiplash-associated disorder.
* Neuropathic pain or neurological disorders (e.g. myasthenia gravis, orofacial dystonia).
* History of psychiatric disorders.
* Pain of dental origin.
* Use of muscle relaxants or other medication that might influence the response to pain.
* Pregnancy or lactation.
* Known hypersensitivity to granisetron or lidocaine
